Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedPage revision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.0%

- Check16 days agoChange DetectedIQVIA Pty Ltd was added to the Collaborators list. The entry 'Iqvia Pty Ltd' was removed and reformatted with correct capitalization.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded the Adv Ther publication citation: Jackson DJ et al. Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2 (Adv Ther. 2026 Feb; 43(2):880-897; doi: 10.1007/s12325-025-03457-4; Epub 2025 Dec 29). Removed the previously listed Adv Ther publication citation that was Online ahead of print (Dec 29, 2025).SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.4.2 was added to the page. The long government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.